Bank of New York Mellon Corp - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 177 filers reported holding BLUEBIRD BIO INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$1,250,857
-6.2%
411,466
+1.5%
0.00%
Q2 2023$1,333,838
+5.2%
405,422
+1.7%
0.00%
Q1 2023$1,267,484
-47.3%
398,580
+14.6%
0.00%
-100.0%
Q4 2022$2,406,904
+17.6%
347,819
+7.5%
0.00%
Q3 2022$2,047,000
+66.2%
323,492
+8.6%
0.00%
Q2 2022$1,232,000
-6.9%
297,912
+9.2%
0.00%
Q1 2022$1,324,000
-50.9%
272,903
+1.1%
0.00%
Q4 2021$2,696,000
-57.7%
269,935
-19.0%
0.00%
-100.0%
Q3 2021$6,372,000
-36.7%
333,456
+5.9%
0.00%
-50.0%
Q2 2021$10,072,000
+49.5%
314,956
+40.9%
0.00%
+100.0%
Q1 2021$6,737,000
-35.8%
223,453
-7.9%
0.00%
-50.0%
Q4 2020$10,500,000
-21.2%
242,655
-1.8%
0.00%
-33.3%
Q3 2020$13,333,000
-13.1%
247,127
-1.6%
0.00%
-25.0%
Q2 2020$15,336,000
+66.9%
251,236
+25.6%
0.00%
+33.3%
Q1 2020$9,191,000
-49.4%
199,976
-3.4%
0.00%
-40.0%
Q4 2019$18,157,000
-6.1%
206,911
-1.7%
0.01%0.0%
Q3 2019$19,334,000
-26.5%
210,574
+1.9%
0.01%
-28.6%
Q2 2019$26,296,000
-22.1%
206,728
-3.6%
0.01%
-22.2%
Q1 2019$33,739,000
+50.8%
214,450
-4.9%
0.01%
+28.6%
Q4 2018$22,366,000
-73.7%
225,455
-61.2%
0.01%
-68.2%
Q3 2018$84,926,000
+73.1%
581,695
+86.1%
0.02%
+69.2%
Q2 2018$49,064,000
-19.9%
312,621
-12.8%
0.01%
-23.5%
Q1 2018$61,234,000
+5.3%
358,619
+9.9%
0.02%
+13.3%
Q4 2017$58,141,000
+72.4%
326,446
+32.9%
0.02%
+66.7%
Q3 2017$33,729,000
+40.7%
245,563
+7.6%
0.01%
+28.6%
Q2 2017$23,964,000
+15.3%
228,114
-0.2%
0.01%
+16.7%
Q1 2017$20,787,000
+63.0%
228,663
+10.7%
0.01%
+50.0%
Q4 2016$12,751,000
-3.5%
206,652
+6.0%
0.00%0.0%
Q3 2016$13,215,000
+82.6%
194,978
+16.6%
0.00%
+100.0%
Q2 2016$7,239,000
+10.5%
167,217
+8.5%
0.00%0.0%
Q1 2016$6,552,000
-31.7%
154,155
+3.3%
0.00%
-33.3%
Q4 2015$9,587,000
-29.0%
149,263
-5.4%
0.00%
-25.0%
Q3 2015$13,494,000
-50.6%
157,735
-2.7%
0.00%
-50.0%
Q2 2015$27,297,000
+38.1%
162,133
-0.9%
0.01%
+60.0%
Q1 2015$19,763,000
+68.4%
163,641
+27.9%
0.01%
+66.7%
Q4 2014$11,737,000
+194.9%
127,976
+15.4%
0.00%
+200.0%
Q3 2014$3,980,000
-32.8%
110,917
-27.8%
0.00%0.0%
Q2 2014$5,922,000
+748.4%
153,536
+400.0%
0.00%
Q1 2014$698,000
+19.1%
30,710
+9.9%
0.00%
Q4 2013$586,000
-37.7%
27,942
-20.0%
0.00%
Q3 2013$940,00034,9080.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q4 2021
NameSharesValueWeighting ↓
Monashee Investment Management LLC 125,000$13,131,0005.55%
Cormorant Asset Management, LP 275,000$28,889,0004.79%
Eventide Asset Management 569,700$59,847,0003.73%
Crosspoint Capital Strategies, LLC 28,937$3,040,0002.66%
Casdin Capital, LLC 65,000$6,828,0002.53%
ARK Investment Management 119,683$12,573,0002.45%
RTW INVESTMENTS, LP 104,383$10,965,0002.31%
Taylor Wealth Management Partners 38,368$4,031,0001.82%
First Light Asset Management, LLC 33,780$3,549,0001.19%
Atika Capital Management LLC 25,000$2,627,0000.92%
View complete list of BLUEBIRD BIO INC shareholders